Lipocine LPCN 深 沪
等待开盘 11-07 09:30:00 美东时间
2.64
+0.080
+3.13%
华盛通- 最 高2.7686
- 今 开2.60
- 成交量 3.15万股
- 最 低 2.60
- 昨 收 2.56
- 总市值 1430.62万
- 52周最高 5.50
- 市盈率 静 --
- 换手率 0.58%
- 52周最低 2.52
- 委 比 97.20%
- 总股本 541.90万
- 历史最高 340.00
- 量 比 1.15
- 振 幅 6.59%
- 历史最低 2.52
- 每 手 1
- 风险率 0.80%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Lipocine Q3 EPS $(0.59) Misses $(0.55) Estimate, Sales $114.574K Miss $238.000K Estimate
Lipocine (NASDAQ:LPCN) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.55) by 8.26 percent. This is a 34.09 percent decrease over losses of $(0.44) per share from the
11-06 21:28
Lipocine Presents LPCN 2401 Clinical Data at ObesityWeek®
SALT LAKE CITY, Nov. 4, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effe...
11-04 21:00
Lipocine Advances Phase 3 Trial for PPD Treatment
Lipocine ( ($LPCN) ) has provided an update. Lipocine Inc. announced progress i...
09-30 21:54
Earnings Outlook For Aytu BioPharma
Aytu BioPharma (NASDAQ:AYTU) is preparing to release its quarterly earnings on ...
09-22 22:02
Lipocine Participates in H.C. Wainwright Investor Conference
Lipocine ( ($LPCN) ) has shared an update. Lipocine announced its participation...
09-05 23:17
Lipocine Announces LPCN 2101 Abstracts Accepted for Presentation at AES 2025
SALT LAKE CITY, Aug. 26, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with eff...
08-26 20:00
HC Wainwright & Co. Reiterates Buy on Lipocine, Maintains $8 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates Lipocine (NASDAQ:LPCN) with a Buy and maintains $8 price target.
08-20 21:11
Lipocine Q2 EPS $(0.41) Misses $(0.40) Estimate, Sales $622.849M Beat $229.000K Estimate
Lipocine (NASDAQ:LPCN) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.40) by 2.5 percent. This is a 26.79 percent increase over losses of $(0.56) per share from the same
08-05 20:17
Lipocine Hosts Virtual Event on LPCN 1154
The latest update is out from Lipocine ( ($LPCN) ). On July 9, 2025, Lipocine h...
07-09 23:28
Lipocine Updates Corporate Presentation for Investors
Lipocine ( ($LPCN) ) just unveiled an announcement. Lipocine has updated its co...
07-02 23:48
